(0.22%) 5 533.50 points
(0.15%) 39 527 points
(0.24%) 19 976 points
(0.67%) $82.09
(-2.04%) $2.55
(0.14%) $2 342.90
(0.19%) $29.62
(-0.56%) $996.30
(-0.28%) $0.931
(-0.27%) $10.65
(-0.13%) $0.790
(1.95%) $87.40
Live Chart Being Loaded With Signals
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States...
Stats | |
---|---|
今日成交量 | 36 911 |
平均成交量 | 60 653 |
市值 | 79.75M |
EPS | $-0.350 ( Q1 | 2024-05-10 ) |
下一个收益日期 | ( $-0.250 ) 2024-08-08 |
Last Dividend | $0.300 ( 2022-05-24 ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.07 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.0230 (0.55%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-17 | Karkus Ted William | Buy | 400 000 | Option (right to buy) |
2024-01-01 | Latkin Jed | Buy | 500 000 | Option (right to buy) |
2024-01-01 | Latkin Jed | Buy | 0 | |
2024-03-17 | Hirsch Warren | Buy | 70 000 | Option (right to buy) |
2024-03-17 | Gleckel Louis Md | Buy | 70 000 | Option (right to buy) |
INSIDER POWER |
---|
22.52 |
Last 98 transactions |
Buy: 8 777 863 | Sell: 8 858 292 |
Prophase Labs Inc 财务报表
Annual | 2023 |
营收: | $44.38M |
毛利润: | $16.24M (36.59 %) |
EPS: | $-0.980 |
FY | 2023 |
营收: | $44.38M |
毛利润: | $16.24M (36.59 %) |
EPS: | $-0.980 |
FY | 2022 |
营收: | $122.65M |
毛利润: | $70.65M (57.61 %) |
EPS: | $1.170 |
FY | 2021 |
营收: | $79.04M |
毛利润: | $41.99M (53.12 %) |
EPS: | $0.540 |
Financial Reports:
No articles found.
Prophase Labs Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1.000 | 2018-06-06 |
Last Dividend | $0.300 | 2022-05-24 |
Next Dividend | $0 | N/A |
Payout Date | 2022-06-03 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $2.40 | -- |
Avg. Dividend % Per Year | 2.00% | -- |
Score | 1.36 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2018 | $1.000 | 44.60% |
2019 | $0.500 | 15.40% |
2020 | $0 | 0.00% |
2021 | $0.300 | 2.84% |
2022 | $0.600 | 8.10% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
24 May 2022 | $0.300 | 13 May 2022 | 25 May 2022 | 03 Jun 2022 |
28 Feb 2022 | $0.300 | 16 Feb 2022 | 01 Mar 2022 | 10 Mar 2022 |
24 May 2021 | $0.300 | 13 May 2021 | 25 May 2021 | 03 Jun 2021 |
02 Dec 2019 | $0.250 | 20 Nov 2019 | 03 Dec 2019 | 12 Dec 2019 |
09 Jan 2019 | $0.250 | 26 Dec 2018 | 10 Jan 2019 | 24 Jan 2019 |
06 Jun 2018 | $1.000 | 08 May 2018 | 21 May 2018 | 05 Jun 2018 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.822 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.262 | 1.200 | -8.74 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.450 | 1.500 | -6.11 | -9.16 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.884 | 0.800 | 5.58 | 4.46 | [1 - 3] |
quickRatioTTM | 1.544 | 0.800 | 5.62 | 4.50 | [0.8 - 2.5] |
cashRatioTTM | 0.0726 | 1.500 | -0.708 | -1.062 | [0.2 - 2] |
debtRatioTTM | 0.172 | -1.500 | 7.14 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -19.55 | 1.000 | -8.35 | -8.35 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.939 | 2.00 | -0.313 | -0.626 | [0 - 30] |
freeCashFlowPerShareTTM | -1.137 | 2.00 | -0.569 | -1.137 | [0 - 20] |
debtEquityRatioTTM | 0.345 | -1.500 | 8.62 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.184 | 1.000 | -0.265 | -0.265 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1.072 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -1.095 | 1.000 | -7.19 | -7.19 | [0.2 - 2] |
assetTurnoverTTM | 0.319 | 0.800 | -1.207 | -0.966 | [0.5 - 2] |
Total Score | -3.16 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -3.20 | 1.000 | -0.424 | 0 | [1 - 100] |
returnOnEquityTTM | -0.450 | 2.50 | -3.93 | -9.16 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.137 | 2.00 | -0.379 | -1.137 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.939 | 2.00 | -0.313 | -0.626 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0924 | 1.500 | -3.95 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.590 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.75 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Prophase Labs Inc
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。